285 related articles for article (PubMed ID: 26153794)
1. PSMA expression is highly homogenous in primary prostate cancer.
Tsourlakis MC; Klein F; Kluth M; Quaas A; Graefen M; Haese A; Simon R; Sauter G; Schlomm T; Minner S
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):449-55. PubMed ID: 26153794
[TBL] [Abstract][Full Text] [Related]
2. PSMA/PSA ratio evaluated by immunohistochemistry may improve diagnosis of prostate cancer.
Jemaa AB; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
J Immunoassay Immunochem; 2014; 35(1):48-59. PubMed ID: 24063616
[TBL] [Abstract][Full Text] [Related]
3. PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis.
Bravaccini S; Puccetti M; Bocchini M; Ravaioli S; Celli M; Scarpi E; De Giorgi U; Tumedei MM; Raulli G; Cardinale L; Paganelli G
Sci Rep; 2018 Mar; 8(1):4254. PubMed ID: 29523813
[TBL] [Abstract][Full Text] [Related]
4. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
Minner S; Wittmer C; Graefen M; Salomon G; Steuber T; Haese A; Huland H; Bokemeyer C; Yekebas E; Dierlamm J; Balabanov S; Kilic E; Wilczak W; Simon R; Sauter G; Schlomm T
Prostate; 2011 Feb; 71(3):281-8. PubMed ID: 20809553
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database.
Bahler CD; Johnson MM; Davicioni E; Zhang J; Cheng L; Green MA; Koch MO
Urology; 2020 Oct; 144():117-122. PubMed ID: 32619596
[TBL] [Abstract][Full Text] [Related]
6. Cellular distribution and heterogeneity of Psa and Psma expression in normal, hyperplasia and human prostate cancer.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Horchani A; Oueslati R
Tunis Med; 2013 Jul; 91(7):458-63. PubMed ID: 24008878
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis.
Mannweiler S; Amersdorfer P; Trajanoski S; Terrett JA; King D; Mehes G
Pathol Oncol Res; 2009 Jun; 15(2):167-72. PubMed ID: 18802790
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of canine prostate-specific membrane antigen.
Schmidt S; Fracasso G; Colombatti M; Naim HY
Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
[TBL] [Abstract][Full Text] [Related]
10. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.
Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY
Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific membrane antigen as a marker of pancreatic cancer cells.
Ren H; Zhang H; Wang X; Liu J; Yuan Z; Hao J
Med Oncol; 2014 Mar; 31(3):857. PubMed ID: 24477651
[TBL] [Abstract][Full Text] [Related]
12. PSMA expression by microvasculature of thyroid tumors - Potential implications for PSMA theranostics.
Bychkov A; Vutrapongwatana U; Tepmongkol S; Keelawat S
Sci Rep; 2017 Jul; 7(1):5202. PubMed ID: 28701709
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
[TBL] [Abstract][Full Text] [Related]
14. The utility of PSMA and PSA immunohistochemistry in the cytologic diagnosis of metastatic prostate carcinoma.
Bernacki KD; Fields KL; Roh MH
Diagn Cytopathol; 2014 Jul; 42(7):570-5. PubMed ID: 24273068
[TBL] [Abstract][Full Text] [Related]
15. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction.
Kusuda Y; Miyake H; Kurahashi T; Fujisawa M
Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
Tolkach Y; Gevensleben H; Bundschuh R; Koyun A; Huber D; Kehrer C; Hecking T; Keyver-Paik MD; Kaiser C; Ahmadzadehfar H; Essler M; Kuhn W; Kristiansen G
Breast Cancer Res Treat; 2018 Jun; 169(3):447-455. PubMed ID: 29455299
[TBL] [Abstract][Full Text] [Related]
17. N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.
Whitaker HC; Shiong LL; Kay JD; Grönberg H; Warren AY; Seipel A; Wiklund F; Thomas B; Wiklund P; Miller JL; Menon S; Ramos-Montoya A; Vowler SL; Massie C; Egevad L; Neal DE
Oncogene; 2014 Nov; 33(45):5274-87. PubMed ID: 24240687
[TBL] [Abstract][Full Text] [Related]
18. PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples.
Antunes AA; Reis ST; Leite KR; Real DM; Sousa-Canavez JM; Camara-Lopes LH; Dall'Oglio MF; Srougi M
Int Braz J Urol; 2013; 39(5):649-56. PubMed ID: 24267108
[TBL] [Abstract][Full Text] [Related]
19. GCPII imaging and cancer.
Foss CA; Mease RC; Cho SY; Kim HJ; Pomper MG
Curr Med Chem; 2012; 19(9):1346-59. PubMed ID: 22304713
[TBL] [Abstract][Full Text] [Related]
20. Insight into the heterogeneity of prostate cancer through PSA-PSMA prostate clones: mechanisms and consequences.
Ben Jemaa A; Bouraoui Y; Oueslati R
Histol Histopathol; 2014 Oct; 29(10):1263-80. PubMed ID: 24788382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
